Gastrointestinal Escalation during Titration Like Zepbound and Wegovy, the most common side effects associated with Retatrutide are gastrointestinal: nausea, diarrhea, vomiting, and constipation
Retatrutide is an investigational injectable triple incretin receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, enhancing insulin secretion, suppressing appetite, and potentially increasing energy expenditure
It is also worth pointing out that regardless of how you measure cardiovascular risk, the treatment for high cholesterol remains the same
These errors arent detectable by visual inspection degraded peptide often appears clear and normal but produces null results or inconsistent biomarker responses
While GLP-1 medications have gained attention for weight management, food manufacturers are responding by developing products that provide greater satiety, protein, fibre, and overall nutritional value